Eli Lilly's next-generation weight loss injection posted record results in obesity trial

6 sources covered this compare →

Coverage diverges in the emphasis placed on the drug's effectiveness and implications. TODAY.com highlights the "stunning" results and compares retatrutide favorably to existing GLP-1 medications, while the Washington Examiner focuses on…